This study aimed to investigate the relationship between miR-122-5p and cell division cycle 25A (CDC25A) in CML and to elucidate the regulatory mechanisms of miR-122-5p. Here, CDC25A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.